Pennell D J, Underwood S R, Manzara C C, Swanton R H, Walker J M, Ell P J, Longmore D B
Magnetic Resonance Unit, Royal Brompton National Heart and Lung Hospital, London, United Kingdom.
Am J Cardiol. 1992 Jul 1;70(1):34-40. doi: 10.1016/0002-9149(92)91386-i.
Cine magnetic resonance imaging (MRI) provides a tomographic method of assessing regional ventricular function in any desired plane. It has not been possible to obtain adequate images during dynamic exercise, and this has limited its value in patients with coronary artery disease (CAD). Therefore, an infusion of dobutamine was used to study 25 patients with exertional chest pain and abnormal exercise electrocardiograms. Areas of abnormal wall motion were compared with areas of abnormal myocardial perfusion imaged by dobutamine thallium emission tomography and with coronary arteriography. Twenty-two patients had significant CAD. Twenty-one (96%) of these patients had reversible myocardial ischemia shown by dobutamine thallium tomography, and 20 (91%) had reversible wall motion abnormalities shown by dobutamine MRI. Comparison of abnormal segments of perfusion and wall motion showed 96% agreement at rest, 90% agreement during stress, and 91% agreement for the assessment of functional reversibility. The normalized magnetic resonance signal intensity of the ischemic segments showed a small but significant reduction when compared with that of normal segments (-67 units [9.2%]; p less than 0.05). Dobutamine infusion was well-tolerated, despite causing chest discomfort in 24 patients (96%). Nine patients (36%) developed a minor dysrhythmia that was usually ventricular premature complexes, but this did not limit infusion, and other side effects were mild. The short plasma half-life of dobutamine makes it ideal as a stress agent for imaging techniques (such as MRI), and these results suggest that it is more effective in the provocation of wall motion abnormalities than is dipyridamole in patients with CAD.
电影磁共振成像(MRI)提供了一种断层扫描方法,可在任何所需平面评估局部心室功能。在动态运动期间无法获得足够的图像,这限制了其在冠状动脉疾病(CAD)患者中的价值。因此,使用多巴酚丁胺输注来研究25例有劳力性胸痛和运动心电图异常的患者。将异常壁运动区域与多巴酚丁胺铊发射断层扫描成像的异常心肌灌注区域以及冠状动脉造影结果进行比较。22例患者患有严重CAD。其中21例(96%)患者通过多巴酚丁胺铊断层扫描显示有可逆性心肌缺血,20例(91%)患者通过多巴酚丁胺MRI显示有可逆性壁运动异常。灌注和壁运动异常节段的比较显示,静息时一致性为96%,应激时一致性为90%,功能可逆性评估的一致性为91%。与正常节段相比,缺血节段的归一化磁共振信号强度显示出虽小但显著的降低(-67单位[9.2%];P<0.05)。尽管24例患者(96%)出现胸部不适,但多巴酚丁胺输注耐受性良好。9例患者(36%)出现轻度心律失常,通常为室性早搏,但这并未限制输注,其他副作用较轻。多巴酚丁胺短的血浆半衰期使其成为成像技术(如MRI)理想的应激剂,这些结果表明,在CAD患者中,多巴酚丁胺在诱发壁运动异常方面比双嘧达莫更有效。